M
MCP Directory CURATED DIRECTORY
911 MCP servers indexed
中文
← Back to directory
COMPARE UP TO 4 SERVERS

Compare MCP servers

Compare scores, permissions, risks, and fit in one decision-focused table.

DimensionMantishackAn autonomous vulnerability-discovery agent for authorized security testing.BioMCPOne binary. One grammar. Evidence from the biomedical sources you already trust.
FMRS49 / 100 · D75 / 100 · B
Reliability8 / 2010 / 20
Security and permissions10 / 2016 / 20
Maintenance8 / 2018 / 20
Documentation13 / 2017 / 20
Setup experience10 / 2014 / 20
Best for
  • Security researchers with explicit authorization.
  • AppSec teams combining automated detection with attacker-simulation validation.
  • Technical users comfortable with an incomplete harness and external tool dependencies.
  • Biomedical researchers
  • Clinicians
  • AI agents that need efficient access to biomedical literature and data analysis
Not for
  • Testing targets without authorization.
  • Users seeking a polished, complete commercial security platform.
  • Users expecting fabricated results when external scanners are unavailable.
  • Users needing to write to upstream databases (read-only)
  • Users requiring direct access to closed datasets (e.g., COSMIC is not directly integrated)
  • Users expecting all advanced features without API keys
Required permissions
  • Requires access to read and analyze the target codebase.
  • Depending on enabled capabilities, may invoke local scanners, solvers, and the CodeQL CLI.
  • Authorization must be established before active or exploit testing; otherwise restrict runs to read-only static analysis.
  • Requires internet access to query public biomedical APIs
  • Optional API keys (NCBI, Semantic Scholar, OpenFDA, etc.) to improve rate limits or unlock features
  • Local read/write access for skills, cache, and local study data (e.g., `~/.local/share/biomcp`)
Risks and side effects
  • Gated exploitation is off by default, but active testing can still affect a target.
  • Missing underlying binaries make corresponding scanning capabilities unavailable.
  • The project describes itself as rough, with known gaps and unfinished external toolchains.
  • CodeQL in particular does not permit commercial use; licenses for all invoked components should be reviewed.
  • Upstream API rate limits may affect performance
  • Some data sources (e.g., KEGG) have licensing terms that restrict non-academic use
  • Features requiring API keys (e.g., OncoKB) may be incomplete without them
  • Local binary installations need regular updates for compatibility
Supported clientsClaude Desktop, Claude Code, Codex, Other MCP stdio clients
Tools1411